Chloropyramine BE study [Power / Sample Size]

posted by Elena777 – Belarus, 2019-03-13 17:17 (678 d 18:41 ago) – Posting: # 20022
Views: 2,766

Dear all! Please share any idea with me. Chloropyramine is an antiallergic drug. We need to conduct BE study with our chloropyramine tablet vs reference Suprastin. But I failed to find any useful data about pharmacokinetics as well as BE reports of other companies and PARs about drugs with such API. My colleagues failed as well. So we have NO information about CVintra and CI for Cmax and AUCt. And we are not able even to suggest anything. There is nothing to rely on in estimation of sample size. Any help will be highly appreciated!

Complete thread:

Activity
 Admin contact
21,307 posts in 4,444 threads, 1,489 registered users;
online 10 (0 registered, 10 guests [including 5 identified bots]).
Forum time: Wednesday 11:59 CET (Europe/Vienna)

Power: That which is wielded by the priesthood of
clinical trials, the statisticians, and a stick which they use
to beta their colleagues.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5